risankizumab
abbvie
['risan', 'crohn', 'ibd']
geert d'haens presents data on the efficacy of risankizumab maintenance in patients with crohn's disease who had a delayed response to induction therapy #uegweek #ibd #gitwitter 
The Lancet Gastroenterology & Hepatology publishes high-quality peer-reviewed research and reviews, comment, and news #gastroenterology #hepatology. IF=45.042